首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1561060

填充饰面製造市场规模、份额、成长分析、按产品、按最终用户、按地区 - 行业预测，2024-2031 年

Fill Finish Manufacturing Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By End User (Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球填充涂料製造市场规模为1,65亿美元，从2023年的179.5亿美元成长到2031年的352.5亿美元，预计复合年增长率为8.80%。

由于生物製药需求的增加、慢性病的流行以及药物输送系统的进步，全球填充涂料製造市场正在稳步成长。人口老化和对个人化医疗的日益关注等关键因素进一步增加了对填充製造服务的需求。管瓶、注射器、药筒和安瓿等消耗品占据了重要的市场占有率，其中预填充式注射器和创新包装解决方案广受欢迎。同时，灌装机、封盖机和检查机等设备随着技术进步而不断发展，提高了製程自动化、效率和准确性，同时减少了污染风险和人为错误。

市场概况
消耗品
- 管瓶
- 管瓶
- 塑胶管瓶
- 管瓶瓶塞
- 预填充式注射器
- 按成分
- 预填充式注射器系统和组件
- 柱塞塞
- 按材质
- 玻璃预灌封预填充式注射器
- 塑胶预灌封预填充式注射器
- 墨水匣
- 其他消耗品
装置
- 依系统类型
- 综合系统
- 独立系统
- 按机器类型
- 自动化机械
- 半自动和手动机器

填充饰面製造市场：依最终用户分类

市场概况
契约製造组织
製药和生物製药公司
其他最终用户

填充饰面製造市场规模：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

IMASPA（Italy）
BD（Becton, Dickinson and Company）（US）
West Pharmaceutical Services, Inc.（US）
Gerresheimer AG（Germany）
AptarGroup, Inc.（US）
Datwyler Holding Inc.（Switzerland）
Berry Global, Inc.（US）
tevanato Group SPA（Italy）
Optima（Germany）
Bausch+Strobel（Germany）
Groninger & Co. GmbH（Germany）
SGD Pharma（France）
Schott（Germany）
Nipro Corporation（Japan）
Bausch Advanced Technology Group（US）
Maquinaria Industrial Dara, SL（Spain）
Steriline SRL（Italy）
Automated Systems of Tacoma, LLC（US）
SiO2 Materials Science（US）
Weiler Engineering, Inc.（US）
Fedegari Autoclavi SPA（Italy）
DWK Life Sciences（Germany）
Rochling SE & Co. KG（Germany）
Terumo Corporation（Japan）
Pacific Vial Manufacturing Inc.（US）
SP Industries（US）

简介目录

Product Code: SQMIG35H2229

Global Fill Finish Manufacturing Market size was valued at USD 16.5 billion in 2022 and is poised to grow from USD 17.95 billion in 2023 to USD 35.25 billion by 2031, growing at a CAGR of 8.80% during the forecast period (2024-2031).

The global fill finish manufacturing market is witnessing steady growth, driven by the rising demand for biopharmaceuticals, the growing prevalence of chronic diseases, and advancements in drug delivery systems. Key factors such as the aging population and increasing focus on personalized medicine further fuel the demand for fill finish manufacturing services. Consumables, including vials, syringes, cartridges, and ampoules, hold a substantial market share, with prefilled syringes and innovative packaging solutions gaining significant traction. Meanwhile, instruments like filling, capping, and inspection machines are evolving with technological advancements, enhancing process automation, efficiency, and accuracy while reducing contamination risks and human error.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fill Finish Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fill Finish Manufacturing Market Segmental Analysis

Global Fill Finish Manufacturing Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Consumables, Instruments. Based on End User, the market is segmented into Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Fill Finish Manufacturing Market

The expanding biotechnology sector, driven by the development of innovative and personalized medicines, is emerging as a key driver for the global fill finish manufacturing market. As biopharmaceutical companies increasingly focus on producing complex and sensitive biologic products, there is a growing demand for advanced fill finish processes to ensure the safe and effective packaging, storage, and delivery of these high-value drugs. The sector's emphasis on precision and sterility, particularly for biologics like monoclonal antibodies, vaccines, and cell and gene therapies, is creating significant growth opportunities. Moreover, the rise in biologic-based treatments and the growing prevalence of chronic diseases are further fueling the need for sophisticated fill finish technologies to meet the stringent regulatory requirements for product safety and efficacy.

Restraints in the Global Fill Finish Manufacturing Market

Ensuring product integrity and preventing contamination during the fill finish process is crucial in pharmaceutical manufacturing. Any contamination or quality issues can lead to serious consequences, such as product recalls and harm to a company's reputation, emphasizing the need for rigorous quality control. This creates significant challenges for the fill finish manufacturing market, as it must implement effective strategies to minimize the risk of contamination. The industry's focus on maintaining high standards is essential to safeguarding product quality and protecting the reputation of pharmaceutical brands.

Market Trends of the Global Fill Finish Manufacturing Market

A notable trend in the global fill finish manufacturing market is the growing adoption of advanced technologies and automation. Fill finish manufacturing, which involves the final steps of pharmaceutical production-filling drug products into vials, syringes, or containers, followed by sealing and labeling-has seen a technological transformation in recent years. The shift towards automated systems and cutting-edge technologies is driven by the need to enhance efficiency, accuracy, and regulatory compliance. By integrating automation, companies can streamline the fill finish process, reducing errors and improving overall productivity, marking a significant evolution in the industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Pricing Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Fill Finish Manufacturing Market by Product

Market Overview
Consumables
- Vials
- Glass Vials
- Plastic Vials
- Vial Stoppers
- Pre-Fillable Syringes
- By Component
- Pre-Fillable Syringe Systems & Components
- Plunger Stoppers
- By Material
- Glass Pre-Fillable Syringes
- Plastic Pre-Fillable Syringes
- Cartridges
- Other Consumables
Instruments
- By System Type
- Integrated Systems
- Standalone Systems
- By Machine Type
- Automated Machines
- Semi-Automated & Manual Machines

Fill Finish Manufacturing Market by End User

Market Overview
Contract Manufacturing Organizations
Pharmaceutical & Biopharmaceutical Companies
Other End Users

Fill Finish Manufacturing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

I.M.A. S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Datwyler Holding Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berry Global, Inc. (US)
- S Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
tevanato Group S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optima (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch+Strobel (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Groninger & Co. GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGD Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schott (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Advanced Technology Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maquinaria Industrial Dara, SL (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Steriline S.R.L. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Automated Systems of Tacoma, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SiO2 Materials Science (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weiler Engineering, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fedegari Autoclavi S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DWK Life Sciences (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rochling SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Vial Manufacturing Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SP Industries (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments